Titan Pharmaceuticals
TTNP
#11013
Rank
โ‚น0.59 B
Marketcap
โ‚น445.93
Share price
-3.76%
Change (1 day)
26.55%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น424.64. In 2023 the company made an earnings per share (EPS) of -โ‚น716.77 an increase over its 2022 EPS that were of -โ‚น1,469.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น716.77-51.22%
2022-โ‚น1,469-15.61%
2021-โ‚น1,741-81.37%
2020-โ‚น9,344-77.52%
2019-โ‚น41,575-56.32%
2018-โ‚น95,183-59.51%
2017-โ‚น2,35,103-371.81%
2016โ‚น86,495-144.35%
2015-โ‚น1,95,009300%
2014-โ‚น48,752-121.54%
2013โ‚น2,26,350-151.38%
2012-โ‚น4,40,512-11.54%
2011-โ‚น4,97,971188.89%
2010-โ‚น1,72,374-10%
2009-โ‚น1,91,527
2007-โ‚น7,85,261-2.38%
2006-โ‚น8,04,414-39.13%
2005-โ‚น13,21,537-16.87%
2004-โ‚น15,89,675-22.43%
2003-โ‚น20,49,3404.9%
2002-โ‚น19,53,57761.9%
2001-โ‚น12,06,621-13.7%
2000-โ‚น13,98,14865.01%
1999-โ‚น8,47,325-35.87%
1998-โ‚น13,21,312-1824.71%
1997โ‚น76,611-102.4%
1996-โ‚น31,98,503

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น844.81-298.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น644.22-251.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น447.86 5.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น72.55-117.08%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.25-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น420.78-0.91%๐Ÿ‡บ๐Ÿ‡ธ USA